Live attenuated human rotavirus vaccine
Sponsors
GlaxoSmithKline
Conditions
Infections, RotavirusRotavirus Gastroenteritis
Phase 3
Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis
CompletedNCT00134732
Start: 2005-07-31End: 2006-05-31Target: 150Updated: 2016-09-23
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
CompletedNCT00169455
Start: 2005-03-31End: 2005-12-31Updated: 2017-01-16
Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India
CompletedNCT00289172
Start: 2006-02-10End: 2006-09-08Target: 360Updated: 2017-05-30